Vigil Neuroscience, Inc.
VIGL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $453 | $399 | $1,010 | $345 |
| Gross Profit | -$453 | -$399 | -$1,010 | -$345 |
| % Margin | – | – | – | – |
| R&D Expenses | $62,306 | $60,934 | $47,444 | $32,330 |
| G&A Expenses | $27,377 | $27,932 | $21,440 | $10,079 |
| SG&A Expenses | $27,377 | $27,932 | $21,440 | $10,079 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$453 | $0 | $0 | $0 |
| Operating Expenses | $89,230 | $88,866 | $68,884 | $42,409 |
| Operating Income | -$89,683 | -$88,866 | -$68,884 | -$42,409 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $5,427 | $6,228 | $579 | -$874 |
| Pre-Tax Income | -$84,256 | -$82,638 | -$68,305 | -$43,283 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$84,256 | -$82,638 | -$68,305 | -$43,252 |
| % Margin | – | – | – | – |
| EPS | -2.07 | -2.13 | -2.16 | -1.57 |
| % Growth | 2.8% | 1.4% | -37.6% | – |
| EPS Diluted | -2.07 | -2.13 | -2.16 | -1.57 |
| Weighted Avg Shares Out | 40,668 | 38,712 | 31,685 | 27,462 |
| Weighted Avg Shares Out Dil | 40,668 | 38,712 | 31,685 | 27,462 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,418 | $6,241 | $623 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $453 | $399 | $78 | $28 |
| EBITDA | -$83,803 | -$88,467 | -$68,227 | -$42,381 |
| % Margin | – | – | – | – |